The European Medicines Agency (EMA), in partnership with the European Commission (EC) and the Heads of Medicines Agencies ...
New report says accelerated approval pathway for early-phase clinical trials could save Poland’s health system millions while ...
France will introduce in 2026 a “fast-track” pathway aimed at accelerating the authorisation of certain mono-national clinical trials. Reserved in particular for early-phase studies, serious diseases ...
Faced with growing dominance from China, governments are transforming clinical trial frameworks to boost R&D activity.